How can we, as a society, do a better job of creating new drugs for our most urgent global health challenges?
Kicking off the 2021 season of the Front Row lecture series, Scripps Research President and CEO Peter Schultz, PhD, discusses how the nonprofit biomedical institute has expanded the bounds of academic research to transform drug development.
Using state-of-the-art drug discovery methods and new approaches to translational medicine, the institute is quickly turning new scientific insights into effective drugs. Schultz also will share updates on Scripps Research’s COVID-19 programs and its growing drug pipeline, which encompasses new treatments for cancer, neurodegenerative disease, osteoarthritis and more.
ABOUT THE FRONT ROW LECTURE SERIES
Take a seat in the front row and listen as some of the world’s foremost scientists introduce you to the innovative medicines and treatments headed your way from Scripps Research. Each one-hour virtual lecture is free and can be enjoyed from the comfort of your home. Learn more at frontrow.scripps.edu.
ABOUT SCRIPPS RESEARCH
Scripps Research is an independent, nonprofit biomedical institute ranked the most influential in the world for its impact on innovation. With campuses in La Jolla, California, and Jupiter, Florida, we are advancing human health through profound discoveries that address pressing medical concerns around the globe.